AstraZeneca Defeats Canada's Patent 'Promise Doctrine' Through Court, Not NAFTA
Executive Summary
Supreme Court of Canada says promise doctrine is not correct approach to determine if a patent has sufficient utility; doctrine has been used to invalidate patents on 22 medicines.